Get the Weekly Intelligence Brief — top committee picks every Sunday.
IRTC · NASDAQ · STOCK

iRhythm Technologies, Inc.

Healthcare Updated August 11, 2026
$121.80
52W $100.85 – $212.00
58/100
$4.00B
-283.4
1.32
AI Committee Verdict
Watch
58/100
Conviction: Contested · 50% agreement · 6 analysts
Contested

Is IRTC Bullish or Bearish?

Mixed. Innellis AI committee rates iRhythm Technologies, Inc. (IRTC) Watch with a composite score of 58/100 , based on 6 analysts with 50% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +1.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -18.17 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 27.4% yoy -- genuine top-line momentum. Value Analyst remains cautious — price-to-book of 37.4x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Revenue growing 27.4% YoY -- genuine top-line momentum — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • Beta of 1.46 means this name should amplify a favorable market regime — Macro
  • News sentiment is positive (+0.20 across 10 articles, 14d) — News
Bear Case
  • Price-to-book of 37.4x prices in significant intangible value — Value
  • ROE of only -20.6% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 4.25 adds balance-sheet risk to the value case — Value
  • High leverage (debt-to-equity 4.25) amplifies downside in a stress scenario — Risk
  • Bollinger bandwidth of 24.9% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
58/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 60%
of 192 Healthcare peers
Value Analyst bearish
32 / 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− Price-to-book of 37.4x prices in significant intangible value
Growth Analyst bullish
85 / 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 27.4% YoY -- genuine top-line momentum
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 4.25) amplifies downside in a stress scenario
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 10 articles, 14d)
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
50.5
Neutral
MACD Histogram
0.821
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$112.40
Resistance
$129.15
Bollinger %B
0.65
Inside Bands
Price vs Moving Averages
EMA 9
$123.17 Below
EMA 21
$120.09 Above
EMA 50
$118.13 Above
EMA 200
$130.11 Below

Fundamental Analysis

Valuation
67
Profitability
25
Financial Health
50
Cash Flow
70
Valuation
P/E Ratio -283.4×
P/B Ratio 21.56×
PEG Ratio -1.18
Dividend Yield 0.00%
52W High $212.00
52W Low $100.85
Quality & Growth
ROE -2916.7%
ROA -436.8%
Gross Margin 7145.4%
Operating Margin -116.7%
Revenue Growth YoY
Debt / Equity 3.91
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -283.4 (inexpensive relative to a 15-40x range); Price-to-book of 21.6x; PEG ratio of -1.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -29.2%; Return on assets of -4.4%; Net margin of -1.7%; Gross margin of 71.5%; Current ratio of 3.87 (healthy short-term liquidity); Debt-to-equity of 3.91; Free cash flow per share is positive (1.18); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full IRTC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore IRTC Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime